WAO guideline for the management of hereditary angioedema

Timothy Craig; Emel Aygoren Pursun; Konrad Bork; Tom Bowen; Henrik Boysen; Henriette Farkas; Anete Grumach; Constance H. Katelaris; Richard Lockey; Hilary Longhurst; William Lumry; Markus Magerl; Immaculada Martinez-Saguer; Bruce Ritchie; Alexander Nast; Ruby Pawankar; Bruce Zuraw; Marcus Maurer

doi:10.1097/WOX.0b013e318279affa

WAO guideline for the management of hereditary angioedema

Timothy Craig, Emel Aygoren Pursun, Konrad Bork, Tom Bowen, Henrik Boysen, Henriette Farkas, Anete Grumach, Constance H. Katelaris, Richard Lockey, Hilary Longhurst, William Lumry, Markus Magerl, Immaculada Martinez-Saguer, Bruce Ritchie, Alexander Nast, Ruby Pawankar, Bruce Zuraw, Marcus Maurer

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1215-1241
Number of pages	27
Journal	Japanese Journal of Allergology
Volume	64
Issue number	9
DOIs	https://doi.org/10.1097/WOX.0b013e318279affa
State	Published - 2015

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1097/WOX.0b013e318279affa

Cite this

Craig, T., Pursun, E. A., Bork, K., Bowen, T., Boysen, H., Farkas, H., Grumach, A., Katelaris, C. H., Lockey, R., Longhurst, H., Lumry, W., Magerl, M., Martinez-Saguer, I., Ritchie, B., Nast, A., Pawankar, R., Zuraw, B., & Maurer, M. (2015). WAO guideline for the management of hereditary angioedema. Japanese Journal of Allergology, 64(9), 1215-1241. https://doi.org/10.1097/WOX.0b013e318279affa

@article{45f30ce02476451186136493313b6799,

title = "WAO guideline for the management of hereditary angioedema",

author = "Timothy Craig and Pursun, {Emel Aygoren} and Konrad Bork and Tom Bowen and Henrik Boysen and Henriette Farkas and Anete Grumach and Katelaris, {Constance H.} and Richard Lockey and Hilary Longhurst and William Lumry and Markus Magerl and Immaculada Martinez-Saguer and Bruce Ritchie and Alexander Nast and Ruby Pawankar and Bruce Zuraw and Marcus Maurer",

note = "Funding Information: From the 1）Department of Medicine, Pediatrics and Graduate Studies, Penn State University, Hershey, PA, 3）2）Center for Pediatric and Juvenile Medicine, J.W. Goethe University, 4）Frankfurt（Main）, Germany, Department of Dermatology, Johannes Gutenberg University Mainz, Mainz, Germany, Departments of Medicine and Pediatrics, University of Cal-gary, Calgary, Canada, 5）HAEi, Orsay, France, 6）3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary, 7）Outpatient Group of Recurrent Infections and Laboratory of Immunology, Faculty of Medicine ABC; Depart8） - ment of Dermatology, Faculty of Medicine, University of S{\~a}o Paulo, S{\~a}o Paulo, Brazil, Department of Medicine, Camp9） - belltown Hospital, University of Western Sydney, Sydney, New South Wales, 10）Australia, Allergy, Asthma and Immunology Associates of Tampa Bay, University of South Florida, Tampa, FL, Department of Immunology, Barts Health NHS Trust, London, United Kingdom, 11）Allergy and Asthma Specialists, Dallas, TX, 12）Department of Dermatol- ogy and Allergy, Allergie-Centrum-Charit{\'e}，Charit{\'e}-Universit{\"a}tsmedizin 14） Berlin, Berlin, Germany, 13）Department of Medicine, University 15） of Alberta, Edmonton, Canada, Division of Allergy, Dept. of Pediatrics, Nippon Medical School, Tokyo, Japan, President WAO, Professor of Medicine, Department of Medicine, University of California San Diego and San Diego VA Healthcare. T. Craig, Research: CSL Behring, Dyax, Pharming, Shire, and Viropharma. Speaker: CSL Behring, Dyax, Shire, and Viropharma. Unrestricted Educational Grants: CSL Behring, Dyax, and Viropharma. Consultant: CSL Behring. E. Ayg{\"o}ren P{\"u}rs{\"u}n has received speaker fees from CSL Behring, Shire, and Viropharma and has served on advisory boards for CSL Behring, Pharming, Shire, and Viropharma. K. Bork: consultant of CSL Behring, Shire, and ViroPharma. T. Bowen, in the past year, has served on an Advisory Board for CSL Behring Canada. H. Boysen is an Executive Director of Hereditary Angioedema Association International. H. Farkas has received speaker fees from Shire and served on Advisory Board for CSL Behring, Shire, Pharming, and Viropharma. A. S. Grumach has served on Advisory Boards and as speaker for Shire（ Brazil）. Dr C. H. Katelaris has served on Advisory Boards for Shire, Australia, and CSL Behring, Australia. R. Lockey is the Past President of World Allergy Association. H. Longhurst: （research）CSL Behring, Shire, and Viropharma. Speaker: CSL Behring, Shire, SOBI, and Viropharma. Unrestricted Educational Grants: CSL Behring and Shire. Consultant: CSL Behring, Shire, and SOBI. W. R. Lumry, Consultant Arrangements: CSL Behring, Dyax, Shire HGT, and Viropharma Pharmaceuticals. Grants/Research Support: CSL Behring, Dyax, Pharming, Shire HGT, Viropharma Pharmaceuticals. Speaker{\textquoteright}s Bureau: CSL Behring, Dyax, Shire HGT, and Viropharma Pharmaceuticals. M. Magerl is or has been a speaker/consultant for Jerini, Shire, Sobi, Viropharma. I. Boccon-Gibod: CSL Behring, Shire, and Viropharma. B. Ritchi（e research）: CSL Behring, Dyax, Pharming, and Shire. B. L. Zuraw is a consultant of Dyax, Shire, BioCryst; research support: Shire. M. Maurer is or has been a speaker/consultant for and/or has received research funding from Biocryst, Jerini, Shire, and Viropharma. I. Martinez-Saguer（ research）: CSL Behring, Shire, Viropharma, and Pharming and speaker fees from CSL Behring and Shire. Advisory Boards for CSL Behring, Shire, and Pharming.",

year = "2015",

doi = "10.1097/WOX.0b013e318279affa",

language = "English (US)",

volume = "64",

pages = "1215--1241",

journal = "Japanese Journal of Allergology",

issn = "0021-4884",

publisher = "Japanese Society of Allergology",

number = "9",

}

Craig, T, Pursun, EA, Bork, K, Bowen, T, Boysen, H, Farkas, H, Grumach, A, Katelaris, CH, Lockey, R, Longhurst, H, Lumry, W, Magerl, M, Martinez-Saguer, I, Ritchie, B, Nast, A, Pawankar, R, Zuraw, B & Maurer, M 2015, 'WAO guideline for the management of hereditary angioedema', Japanese Journal of Allergology, vol. 64, no. 9, pp. 1215-1241. https://doi.org/10.1097/WOX.0b013e318279affa

TY - JOUR

T1 - WAO guideline for the management of hereditary angioedema

AU - Craig, Timothy

AU - Pursun, Emel Aygoren

AU - Bork, Konrad

AU - Bowen, Tom

AU - Boysen, Henrik

AU - Farkas, Henriette

AU - Grumach, Anete

AU - Katelaris, Constance H.

AU - Lockey, Richard

AU - Longhurst, Hilary

AU - Lumry, William

AU - Magerl, Markus

AU - Martinez-Saguer, Immaculada

AU - Ritchie, Bruce

AU - Nast, Alexander

AU - Pawankar, Ruby

AU - Zuraw, Bruce

AU - Maurer, Marcus

N1 - Funding Information: From the 1）Department of Medicine, Pediatrics and Graduate Studies, Penn State University, Hershey, PA, 3）2）Center for Pediatric and Juvenile Medicine, J.W. Goethe University, 4）Frankfurt（Main）, Germany, Department of Dermatology, Johannes Gutenberg University Mainz, Mainz, Germany, Departments of Medicine and Pediatrics, University of Cal-gary, Calgary, Canada, 5）HAEi, Orsay, France, 6）3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary, 7）Outpatient Group of Recurrent Infections and Laboratory of Immunology, Faculty of Medicine ABC; Depart8） - ment of Dermatology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil, Department of Medicine, Camp9） - belltown Hospital, University of Western Sydney, Sydney, New South Wales, 10）Australia, Allergy, Asthma and Immunology Associates of Tampa Bay, University of South Florida, Tampa, FL, Department of Immunology, Barts Health NHS Trust, London, United Kingdom, 11）Allergy and Asthma Specialists, Dallas, TX, 12）Department of Dermatol- ogy and Allergy, Allergie-Centrum-Charité，Charité-Universitätsmedizin 14） Berlin, Berlin, Germany, 13）Department of Medicine, University 15） of Alberta, Edmonton, Canada, Division of Allergy, Dept. of Pediatrics, Nippon Medical School, Tokyo, Japan, President WAO, Professor of Medicine, Department of Medicine, University of California San Diego and San Diego VA Healthcare. T. Craig, Research: CSL Behring, Dyax, Pharming, Shire, and Viropharma. Speaker: CSL Behring, Dyax, Shire, and Viropharma. Unrestricted Educational Grants: CSL Behring, Dyax, and Viropharma. Consultant: CSL Behring. E. Aygören Pürsün has received speaker fees from CSL Behring, Shire, and Viropharma and has served on advisory boards for CSL Behring, Pharming, Shire, and Viropharma. K. Bork: consultant of CSL Behring, Shire, and ViroPharma. T. Bowen, in the past year, has served on an Advisory Board for CSL Behring Canada. H. Boysen is an Executive Director of Hereditary Angioedema Association International. H. Farkas has received speaker fees from Shire and served on Advisory Board for CSL Behring, Shire, Pharming, and Viropharma. A. S. Grumach has served on Advisory Boards and as speaker for Shire（ Brazil）. Dr C. H. Katelaris has served on Advisory Boards for Shire, Australia, and CSL Behring, Australia. R. Lockey is the Past President of World Allergy Association. H. Longhurst: （research）CSL Behring, Shire, and Viropharma. Speaker: CSL Behring, Shire, SOBI, and Viropharma. Unrestricted Educational Grants: CSL Behring and Shire. Consultant: CSL Behring, Shire, and SOBI. W. R. Lumry, Consultant Arrangements: CSL Behring, Dyax, Shire HGT, and Viropharma Pharmaceuticals. Grants/Research Support: CSL Behring, Dyax, Pharming, Shire HGT, Viropharma Pharmaceuticals. Speaker’s Bureau: CSL Behring, Dyax, Shire HGT, and Viropharma Pharmaceuticals. M. Magerl is or has been a speaker/consultant for Jerini, Shire, Sobi, Viropharma. I. Boccon-Gibod: CSL Behring, Shire, and Viropharma. B. Ritchi（e research）: CSL Behring, Dyax, Pharming, and Shire. B. L. Zuraw is a consultant of Dyax, Shire, BioCryst; research support: Shire. M. Maurer is or has been a speaker/consultant for and/or has received research funding from Biocryst, Jerini, Shire, and Viropharma. I. Martinez-Saguer（ research）: CSL Behring, Shire, Viropharma, and Pharming and speaker fees from CSL Behring and Shire. Advisory Boards for CSL Behring, Shire, and Pharming.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84955507861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955507861&partnerID=8YFLogxK

U2 - 10.1097/WOX.0b013e318279affa

DO - 10.1097/WOX.0b013e318279affa

M3 - Review article

C2 - 26657910

AN - SCOPUS:84955507861

SN - 0021-4884

VL - 64

SP - 1215

EP - 1241

JO - Japanese Journal of Allergology

JF - Japanese Journal of Allergology

IS - 9

ER -

WAO guideline for the management of hereditary angioedema

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this